Screener
bioAffinity Technologies, Inc. BIAF Q2 2026 earnings
Reported August 7, 2026 · Before market open
Revenue$1.5MMiss by $190.4K
EPS-$0.64Beat by $1.46
Revenue estimate$1.7M
EPS estimate-$2.10
Next report
Nov 18, 2026 (in 2 months)Revenue estimate$1.9M
EPS estimate-$31.50
Versus estimates
Revenue
Diluted EPS
FAQ
- When did bioAffinity Technologies, Inc. report Q2 2026 earnings?
- bioAffinity Technologies, Inc. (BIAF) reported Q2 2026 earnings on August 7, 2026 before market open.
- What were bioAffinity Technologies, Inc.'s Q2 2026 revenue and EPS?
- bioAffinity Technologies, Inc. reported revenue of $1.5M and eps of $-0.64 for Q2 2026.
- Did bioAffinity Technologies, Inc. beat estimates in Q2 2026?
- Revenue missed the consensus estimate of $1.7M by $190.4K. EPS beat the consensus estimate of $-2.10 by $1.46.
- How did bioAffinity Technologies, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 19.0% from $1.3M a year earlier and eps grew 83.6% from $-3.90.
- Where can I find bioAffinity Technologies, Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001493152-26-036486) and the 10-Q periodic report (0001493152-26-036619) directly on SEC EDGAR. The filing index links above go to sec.gov.
